[1] Shibuya M.Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases[J]. J Biochem, 2013, 153(1): 13-19. [2] Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, et al. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer[J]. Int J Mol Sci, 2017, 18(1): 197. [3] Battaglin F, Puccini A, Intini R, et al.The role of tumor angiogenesis as a therapeutic target in colorectal cancer[J]. Expert Rev Anticancer Ther, 2018, 18(3): 251-266. [4] Song Y, Zhao Y, Ding X, et al.microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R[J]. Am J Cancer Res, 2018, 8(3): 435-449. [5] 陈功, 邱萌, 张俊. 结直肠癌规范化诊疗[M].长沙:中南大学出版社,2015. [6] 许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志, 2006, 6(1): 4-4. [7] 许晓阳,吴淑华,孙晨博,等.结直肠癌中PHLPP2、PTEN与p-Akt1表达的相关性及其临床意义[J].临床与实验病理学杂志, 2018,15(8):827-833. [8] 曹建,万相斌,孙淼淼,等. 结直肠癌组织IRS-2蛋白表达临床意义[J].中华肿瘤防治杂志, 2018,25(20):1440-1445. [9] Macarulla T,Montagut C,Francisco Javier Sánchez-Martin, et al. The role of PIGF Blockade in the Treatment of Colorectal Cancer: Overcoming the Pitfalls:VEGF pathway as a target for colorectal cancer[J]. Exp Opin Biol Ther, 2019,20(1):781-788. [10] 岳芙蓉, 彭科瑜,张力. PI3K/AKT/mTOR通路在结直肠癌中的表达及靶向治疗研究[J]. 现代消化及介入诊疗,2020,025(2):178-182. [11] Li H,Lai Z,Yang H,et al.Hedyotis diffusa Willd. inhibits VEGF-C-mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways[J]. Oncology Reports,2019,42(3):670-676. [12] 朱凯旋,谈思源,陈平. 结直肠癌组织中GLUT-1和VEGF-A的表达与临床病理特征及预后的关系[J]. 中国现代普通外科进展, 2018, 13(11): 878-882. [13] 蒋润梅, 田智, 廖江涛, 等. Eag1和VEGF在结直肠癌组织中的表达及意义[J]. 国际肿瘤学杂志, 2018, 45(2): 80-86. [14] Waniczek,nietura,Lorenc,et al. Assessment of PI3K/AKT/PTEN signaling pathway activity in colorectal cancer using quantum dotconjugated antibodies[J]. Oncol Lett, 2018, 7(10): 467-475. [15] Waniczek D, nietura,Mirosaw,Lorenc Z,et al. Assessment of PI3K/AKT/PTEN signaling pathway activity in colorectal cancer using quantum dotconjugated antibodies[J]. Oncology Letters,2018,34(13):992-1002. [16] Fangfang, Zhikuan, Chaonan,et al. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway[J]. Gene,2019,17(5):489-496. [17] Ancheng,Qin,Weifeng,et al. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression[J]. Int J Mol Med,2018,16(19):732-740. [18] 王立春,白鹏宇,庞婧,等.缺氧诱导因子1α和血管内皮生长因子与结直肠癌患者临床病理特征及预后关系的Meta分析[J].广西医学,2019,41(18):2350-2358. [19] Park, Ye-Lim,Kim, Hwang-Phill, Cho, et al. Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations[J]. Int J Cancer, 2019, 15(20): 593-599. [20] 顾玉兰, 丘佳明, 蒋延旺, 等. 结直肠癌中VEGF-C和MMP-2蛋白表达量与肿瘤侵袭转移关系的研究[J]. 现代肿瘤医学, 2019, 27(9): 1576-1580. |